Litman’s “America Unleashed” Defense Pitch: Four Real Microcaps, All Four Down Since the Tease

The Hook

The hook here is a date and a place: October 12, Washington DC, the annual meeting of the Association of the United States Army, better known as AUSA. The promo from Altimetry’s Microcap Confidential service, presented by Nick Litman of the Litman & Swan research shop, frames that conference as the moment when “kingmakers” gather to “hand-pick” the winners of what it calls the “$1.5 trillion defense overhaul.” The premise is a post-conflict America, specifically after a US conflict with Iran, writing a check to rebuild and modernize its arsenal. That angle gets the deep-dive treatment in our “Defense Stocks: What Investors Need to Know” piece.

Let’s pause on that framing, because it matters. AUSA is a real event. It is one of the largest defense trade shows in the country, held every fall in DC, where contractors large and small show off hardware to military buyers. That part is accurate. What the promo layers on top of it, the idea of “kingmakers hand-picking” a handful of tiny winners at a trade show, is a narrative device. Trade shows are where deals get discussed. They are not where the Department of Defense quietly anoints a few microcaps to go up 23-fold.

The pitch itself is a four-stock reveal tied to a subscription. Microcap Confidential runs $2,000 a year, there are no refunds, and the only flexibility is a 30-day window to transfer your subscription to another Altimetry letter. That is the business end of the promo, and it is worth keeping in view while we walk through the argument.

The Big Claim

The headline claim is a “23-fold” gain tease, wrapped in some of the most urgent language the firm has used in a while. The centerpiece quote is this: “Days from Now, a Desperate, Multi-Trillion-Dollar White House Move to SAVE America Will Shock the Market… investors could multiply their money as much as 23-fold from here.”

That “23-fold” is the load-bearing number of the entire pitch. The mechanism for reaching it is spelled out in two more quoted lines. First: “Autonomous drone warfare alone is poised to receive a 24,000% increase in funding.” Second: “And orders of THAAD and Patriot missiles are poised to surge 9X and 28X.”

The third plank of the argument is a direction instruction. The promo says, in effect, do not buy the primes. “You don’t want to own the gigantic defense contractors… You want the stocks that are still operating in the shadows… the tiny and obscure microcaps.” That is the thesis in a single sentence: the money will flow to the small suppliers, not the giants, so buy the small suppliers.

Northrop Grumman (NOC) shows up in the presentation, but only as passing context, described as a “cash cow.” It is not one of the four picks. That distinction matters later, when we look at how the actual stocks have traded.

The Mechanism

The mechanism is a defense rearmament story, and it is worth taking seriously because the direction is real. A prolonged rearmament cycle after a shooting conflict with a regional power would, in fact, pour money into the defense industrial base. Munitions get expended, inventories get restocked, and the small, specialized suppliers who make the parts no one thinks about tend to see order books swell. None of that is controversial.

The four names the promo actually recommends map cleanly onto that thesis.

Graham Corporation (GHM) is the most interesting of the bunch. It makes engineered fluid, vacuum, and heat-transfer equipment, and it recently acquired FlackTek, the maker of a “bladeless mixer” called the Mega FlackTek that is used to mix solid rocket fuel and other energetic materials. Graham has also been named as an Anduril partner, which ties it to the autonomous-systems side of the story the promo is selling. The fundamentals are genuinely solid: net sales up about 30% year over year, a record backlog of roughly $550 million, and zero debt.

Espey Mfg (ESP) makes power supplies and transformers for military and industrial use, and it is currently expanding a facility with Navy funding as a sole-source supplier. Frequency Electronics (FEIM) builds precision timing and frequency-control gear, the kind of thing that keeps missile guidance and radar synchronized, and it sits squarely in the THAAD and Patriot ecosystem the promo names. Taylor Devices (TAYD) makes shock absorbers and dampers, including seismic and defense applications.

These are all real companies with real defense revenue. That is the honest core of the pitch. The question is whether the specific numbers attached to them hold up, and whether the stocks have actually done what the pitch implied they would.

The Real Pick

Current prices are as of the October 27, 2026 close, from Polygon.

Northrop Grumman (NOC), the “cash cow” that appears only as passing context and is not one of the picks, closed at $551.23 with a market cap of about $78.3 billion. Its tease price was $480.72, which puts it up about 17.6% over the same window.

Does the Math Check Out

This is where the promo and reality part ways, and the gap is instructive.

Start with the three headline multipliers. A “24,000% increase in drone funding” and “THAAD and Patriot orders surging 9X and 28X” are attention-grabbing numbers, but they describe total program-level funding, not revenue that flows directly and evenly to these four microcaps. A 24,000% increase in a single line item sounds enormous until you realize it is an increase off a very small base, and that the dollars get spread across thousands of suppliers over a decade. THAAD and Patriot orders surging 9X and 28X, if that happens, accrues primarily to the primes, Raytheon and Lockheed, who assemble the systems, plus their tier-one suppliers. A small timing and frequency-control shop like FEIM, or a shock-absorber maker like TAYD, is a component supplier many steps removed from the headline dollar. The multiplier on total funding and the multiplier on any one microcap’s revenue are not the same number, and the promo never does that translation. It stacks the big, alarming percentages and lets the reader assume the microcaps inherit them.

Second, the “23-fold” tease. Where does a 23-fold gain come from? The promo points to the AUSA conference and leans on cherry-picked success stories from past shows. The examples it cites are companies like Kaman (KAMN), up about 147%, and EOS Energy (EOS), up about 148%. Those are real past moves, but they are two winners plucked from a sea of defense names, and neither is remotely a 23-fold result. A 147% gain is a 2.47X, not 23X. To get to 23-fold you need a microcap to become a mid-cap or large-cap, and there is no mechanism in the pitch that explains how any of these four suppliers does that. The 23-fold number is a ceiling assembled from the most optimistic reading of a few outliers, not a forecast grounded in any of these companies’ actual addressable markets.

Third, and most telling, is the calendar. The AUSA catalyst date of October 12 has already passed. If the conference was the moment the “kingmakers” anointed the winners, the market has now had two weeks to react. It reacted by selling. All four microcaps are down since their tease prices: GHM down 17.1%, ESP down 11.5%, FEIM down 10.4%, and TAYD down 5.0%. Meanwhile the “cash cow” the promo told you to ignore, Northrop, is up 17.6%. We break down that angle in our “Missile Defense Stocks: What Investors Need to Know” piece.

Finally, the “$1.5 trillion defense overhaul” itself. That budget is not yet law. As of this writing the federal government is running on continuing resolutions, and the real appropriations fight lands after the November elections. The $1.5 trillion figure is a proposal, a talking point, not appropriated money. A lot can change between a campaign-scale number and a signed defense appropriation, and the promo treats the top-line figure as if it were already in the bank.

The Verdict

There are two separate questions here, and they deserve separate answers.

Is defense rearmament a real multi-year tailwind? Yes. Munitions restocking, drone proliferation, and precision-strike demand are all genuine, durable spending trends, and the small specialized suppliers who feed those programs will, on the whole, do more business over the coming years than they did over the last few. That part of the argument is sound, and Graham’s record backlog and Espey’s Navy-funded expansion are tangible proof that the orders are real and arriving.

Are these four microcaps an unproven basket that has not validated yet? Also yes. Every one of them is down since the tease, the “23-fold” number is a cherry-picked outlier assembled without a mechanism, and the headline funding multipliers do not translate to these suppliers the way the promo implies. The AUSA catalyst came and went with the stocks lower, not higher.

So the honest read is this: if you believe in defense rearmament, these are four legitimate, small, real businesses worth studying on their own fundamentals, not four tickets to a 23-fold windfall. The pitch overpromises on the urgency and under-delivers on the math, and the one name it told you to skip is the one that has actually risen. Do not buy the 23-fold story. Buy the businesses, if you buy anything at all, after reading their own filings.

What They Got Right

• The direction is correct. Defense rearmament and munitions restocking are real, multi-year spending trends, and the small suppliers who feed them stand to benefit.
• The four picks are real operating companies with genuine defense revenue, not pre-revenue concept stocks. Graham’s 30% sales growth and $550 million backlog, and Espey’s Navy-funded facility expansion, are concrete evidence the demand is real.
• The instinct to look past the primes is not wrong. Small, specialized suppliers do have more torque than the giants when a specific program ramps, and the promo is right that the big contractors are already fully valued.
• Graham’s FlackTek acquisition and Anduril partnership are legitimate, specific hooks that tie it to both solid rocket fuel and autonomous systems, which is more research depth than most microcap promos show.
• The offer terms are at least stated plainly: a $2,000 subscription with no refunds, and the promo names its picks rather than hiding them behind a paywall.

What They Got Wrong

• The “23-fold” tease is assembled from cherry-picked past AUSA winners, KAMN at 147% and EOS at 148%, neither of which is remotely a 23-fold result, and no mechanism is offered for how any of these four gets there.
• The headline multipliers, a 24,000% drone-funding increase and 9X and 28X THAAD and Patriot surges, describe program-level dollars that do not flow evenly to these four microcap suppliers, and the promo never does that translation.
• The AUSA catalyst date of October 12 has already passed, and all four recommended stocks are down since the tease, so the “kingmakers hand-picking winners” narrative did not play out in price.
• The “$1.5 trillion defense overhaul” is treated as appropriated money when it is not yet law; the government is on continuing resolutions and the real budget fight comes after the November elections.
• The promo tells readers to ignore the “gigantic defense contractors” and buy the microcaps, yet the one big contractor named, Northrop, is up 17.6% while all four microcaps are down.

Compliance Disclaimer

This is not financial advice. NewsletterVetter has no position in any stock mentioned.

NewsletterVetter is an independent publication. We receive compensation from some of the services we review through affiliate links. Nothing on this site is investment advice.